治疗2型糖尿病新药捷诺达中国上市
治疗2型糖尿病新药捷诺达中国上市: 新快报讯 全球首个治疗2型糖尿病的新型口服片剂捷诺达（西格列汀二甲双胍片）已获国家食品药品监督管理局批准正式在中国上市。捷诺达是首个口服降糖治疗药物二肽基肽酶4（DPP-4）抑制剂捷诺维家族的 ...
Chinese spend more on diapers and Colgate despite economic woes
... economy. China's economic slump after the pandemic has weighed on sales at consumer packaged goods companies, who had targeted the world's second ... View article...